Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heffner

Showing results (891-900 of 1,030) with videos related to

Pageof 103
Sort By:
The American Journal of Psychiatry|May 3, 2002
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorderLynn E DeLisi, Sarah H Shaw, Timothy J Crow, et al.
Blood|January 7, 2018
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapySteven Coutre, Michael Choi, Richard R Furman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2019
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin LymphomaBrad S Kahl, Mehdi Hamadani, John Radford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive careH K Holland, S P Dix, R B Geller, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|January 10, 2019
Cognitive Behavioral Therapy for Insomnia Reduces Depression in Cancer SurvivorsAnita R Peoples, Sheila N Garland, Wilfred R Pigeon, et al.
Journal of Medicinal Chemistry|March 26, 1998
Aminopyrimidines with high affinity for both serotonin and dopamine receptorsD Wustrow, T Belliotti, S Glase, et al.
Journal of Medicinal Chemistry|September 23, 2000
Thiazoloindans and thiazolobenzopyrans: a novel class of orally active central dopamine (partial) agonistsL A van Vliet, N Rodenhuis, H Wikström, et al.
Journal of Medicinal Chemistry|December 22, 1999
A series of 6- and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: discovery of a potential atypical antipsychotic agentT R Belliotti, D J Wustrow, W A Brink, et al.
Journal of Medicinal Chemistry|August 24, 2000
Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)L A van Vliet, N Rodenhuis, D Dijkstra, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
Modeling patient variants of <i>Cnot1</i> and <i>Cdc42bpb</i> results in distinct forms of congenital diaphragmatic hernia in miceEric L Bogenschutz, Cynthia Carpenter, Ameleen Wong, et al.
Pageof 103

Showing results (891-900 of 1,030) with videos related to

Sort By:
Pageof 103
The American Journal of Psychiatry|May 3, 2002
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorderLynn E DeLisi, Sarah H Shaw, Timothy J Crow, et al.
Blood|January 7, 2018
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapySteven Coutre, Michael Choi, Richard R Furman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2019
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin LymphomaBrad S Kahl, Mehdi Hamadani, John Radford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive careH K Holland, S P Dix, R B Geller, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|January 10, 2019
Cognitive Behavioral Therapy for Insomnia Reduces Depression in Cancer SurvivorsAnita R Peoples, Sheila N Garland, Wilfred R Pigeon, et al.
Journal of Medicinal Chemistry|March 26, 1998
Aminopyrimidines with high affinity for both serotonin and dopamine receptorsD Wustrow, T Belliotti, S Glase, et al.
Journal of Medicinal Chemistry|September 23, 2000
Thiazoloindans and thiazolobenzopyrans: a novel class of orally active central dopamine (partial) agonistsL A van Vliet, N Rodenhuis, H Wikström, et al.
Journal of Medicinal Chemistry|December 22, 1999
A series of 6- and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: discovery of a potential atypical antipsychotic agentT R Belliotti, D J Wustrow, W A Brink, et al.
Journal of Medicinal Chemistry|August 24, 2000
Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)L A van Vliet, N Rodenhuis, D Dijkstra, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
Modeling patient variants of <i>Cnot1</i> and <i>Cdc42bpb</i> results in distinct forms of congenital diaphragmatic hernia in miceEric L Bogenschutz, Cynthia Carpenter, Ameleen Wong, et al.
Pageof 103